Key Quantitative Figures and Dates
- Amount Raised: ₹1,62,50,000 (₹1.63 crore)
- Date of Fund Raising: October 14, 2019
- Report Period: Quarter ended September 30, 2026
- Funds Utilized: ₹1,62,50,000 (100% of the amount raised)
- Date of Full Utilization: The funds were fully utilized in the quarter ended December 31, 2023, as per a note in the statement.
Parties Involved
- Listed Entity: Continental Chemicals Limited (Scrip Code: 506935, ISIN: INE423K01015)
- Stock Exchange: Bombay Stock Exchange Limited
- Signatories: The disclosure was signed by Sakshi Dhawan, Company Secretary (Membership No: ACS 33279), and Naresh Kumar Chibba, Managing Director.
- Audit Committee: The statement was reviewed and approved by the company's audit committee.
- Monitoring Agency: Not Applicable.
Stated Rationale and Object of Fund Raising
The company raised the funds specifically for working capital requirements. The disclosure confirms that the objects for the use of funds were not modified at any point.
Deviation / Variation Status
The company has explicitly stated that there is NO deviation or variation in the use of the funds raised. The entire amount was used for the originally stated object (working capital). Consequently, the fields for explanation of deviation, shareholder approval date, and auditor comments are marked 'Not Applicable'.
Financial and Operational Impact
As the funds have been fully utilized since December 2023 and there is no deviation reported for the current quarter, the financial impact of this specific disclosure is nil. The amount of deviation/variation for the quarter is reported as ₹0.